Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem
NCT ID: NCT00951145
Last Updated: 2013-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medium Term Survivorship of Cementless THA Performed Using the Bone Preservation Tri-Lock Femoral Stem
NCT01566916
Fitmore Versus CLS Stem in Total Hip Arthroplasty. Bilateral One-stage Operations
NCT03112785
Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem
NCT01614028
The Metaphyseal Hip Prosthesis - Total Hip
NCT01501955
Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty
NCT02247791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with hip fracture undergoing THA will also be included.
3. Patients willing and able to comply with follow-up requirements and self-evaluations.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stryker Orthopaedics
INDUSTRY
Rothman Institute Orthopaedics
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rothman Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Parvizi Javad, MD
Role: PRINCIPAL_INVESTIGATOR
Rothman Institute
Hozack William, MD
Role: PRINCIPAL_INVESTIGATOR
Rothman Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rothman Institute
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIFJPAR 09-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.